{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:21:41Z","timestamp":1768407701481,"version":"3.49.0"},"reference-count":64,"publisher":"The Pediatric Pharmacy Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:p>Children often experience viral illnesses causing respiratory symptoms. Frequently, nonprescription medications are used in an attempt to decrease the severity and frequency of cough and cold symptoms. Cough and cold medications (CCMs) are not appropriate for all age groups and can have serious adverse effects, including death, especially when used incorrectly. Data surrounding the safety and efficacy of CCMs in patients younger than 6 years are lacking. Currently, the US Food and Drug Administration (FDA) does not recommend the use of cough and cold products that contain an antihistamine or decongestant in children younger than 2 years. Other treatments used by patients for cold symptoms include non-pharmacologic therapies or complementary alternative medications (CAMs), such as zinc or echinacea. Given this is a common ailment for pediatric patients, pharmacists should be knowledgeable about the risks and benefits of each of these therapies to make safe recommendations for patients and their families. This review discusses various cough and cold therapies and the recommendations for their use in pediatric patients.<\/jats:p>","DOI":"10.5863\/1551-6776-30.1.17","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T14:25:34Z","timestamp":1745245534000},"page":"17-26","source":"Crossref","is-referenced-by-count":2,"title":["The Use and Safety of Cough and Cold Medications in the Pediatric Population"],"prefix":"10.5863","volume":"30","author":[{"given":"Jenna","family":"Summerlin","sequence":"first","affiliation":[{"name":"Pharmacy Practice Division (JS), The University of Texas at Austin, Austin, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea S.","family":"Eiland","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice (LSE), Auburn University Harrison College of Pharmacy, Auburn, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"key":"i2331-348X-30-1-17-b01","article-title":"Preventing and treating common cold","unstructured":"Centers for Disease Control and Prevention. Preventing and treating common cold. Accessed October 31, 2023. https:\/\/www.cdc.gov\/antibiotic-use\/pdfs\/Common-Cold-H.pdf"},{"issue":"(8)","key":"i2331-348X-30-1-17-b02","series-title":"Paediatr Child Health","first-page":"493","article-title":"Colds in children","volume":"10","year":"2005","unstructured":"Annonomous. Colds in children. Paediatr Child Health. 2005;10(8):493\u2013495."},{"key":"i2331-348X-30-1-17-b03","series-title":"Cough and Cold Remedies for the Treatment of Acute Respiratory Infections in Young Children","article-title":"Child and Adolescent Health Development","year":"2001","unstructured":"World Health Organization. Child and Adolescent Health Development. Cough and Cold Remedies for the Treatment of Acute Respiratory Infections in Young Children. World Health Organization; 2001."},{"issue":"(2)","key":"i2331-348X-30-1-17-b04","series-title":"Pediatrics","first-page":"e323","article-title":"Cough and cold medication use by US children, 1999-2006: results from the Slone survey","volume":"122","author":"Vernacchio","year":"2008","unstructured":"Vernacchio L, Kelly JP, Kaufman DW, Mitchell AA. Cough and cold medication use by US children, 1999-2006: results from the Slone survey. Pediatrics. 2008;122(2):e323\u2013e329."},{"key":"i2331-348X-30-1-17-b05","article-title":"Should you give kids medicine for coughs and colds?","year":"January 2023","unstructured":"US Food and Drug Administration. Should you give kids medicine for coughs and colds? January 2023. Accessed October 31, 2023. https:\/\/www.fda.gov\/consumers\/consumer-updates\/should-you-give-kids-medicine-coughs-and-colds"},{"key":"i2331-348X-30-1-17-b06","article-title":"Use caution when giving cough and cold products to kids","year":"February 8, 2018","unstructured":"US Food and Drug Administration. Use caution when giving cough and cold products to kids. February 8, 2018. Accessed November 1, 2023. https:\/\/www.fda.gov\/drugs\/special-features\/use-caution-when-giving-cough-and-cold-products-kids"},{"issue":"(23)","key":"i2331-348X-30-1-17-b07","series-title":"N Engl J Med","first-page":"2321","article-title":"Over the counter but no longer under the radar\u2013pediatric cough and cold medications","volume":"357","author":"Sharfstein","year":"2007","unstructured":"Sharfstein JM, North M, Serwint JR. Over the counter but no longer under the radar\u2013pediatric cough and cold medications. N Engl J Med. 2007;357(23):2321\u20132324."},{"key":"i2331-348X-30-1-17-b08","series-title":"MMWR Morb Mortal Wkly Rep","first-page":"1","article-title":"Infant deaths associated with cough and cold medications-two states, 2005","volume":"56","author":"Srinivasan","year":"2007","unstructured":"Srinivasan A, Budnitz M, Shehab N, Cohen A. Infant deaths associated with cough and cold medications-two states, 2005. MMWR Morb Mortal Wkly Rep. 2007;56:1\u20134."},{"issue":"(1)","key":"i2331-348X-30-1-17-b09","series-title":"Acad Pediatr","first-page":"64","article-title":"Physician and parent response to the FDA advisory about use of over-the-counter cough and cold medications","volume":"10","author":"Garbutt","year":"2010","unstructured":"Garbutt JM, Sterkel R, Banister C, et al. Physician and parent response to the FDA advisory about use of over-the-counter cough and cold medications. Acad Pediatr. 2010;10(1):64\u201369."},{"issue":"(43)","key":"i2331-348X-30-1-17-b10","series-title":"MMWR Morb Mortal Wkly Rep","first-page":"1180","article-title":"Centers for Disease Control and Prevention. Revised product labels for pediatric over-the-counter cough and cold medicines","volume":"57","year":"2008","unstructured":"Centers for Disease Control and Prevention. Revised product labels for pediatric over-the-counter cough and cold medicines. MMWR Morb Mortal Wkly Rep. 2008;57(43):1180."},{"issue":"(5 pt 1)","key":"i2331-348X-30-1-17-b11","series-title":"J Pediatr","first-page":"799","article-title":"Efficacy of cough suppressants in children","volume":"122","author":"Taylor","year":"1993","unstructured":"Taylor JA, Novack AH, Almquist JR, Rogers JE. Efficacy of cough suppressants in children. J Pediatr. 1993;122(5 pt 1):799\u2013802."},{"issue":"(1)","key":"i2331-348X-30-1-17-b12","series-title":"Pediatrics","first-page":"e85","article-title":"Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents","volume":"114","author":"Paul","year":"2004","unstructured":"Paul IM, Yoder KE, Crowell KR, et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics. 2004;114(1):e85\u2013e90."},{"issue":"(12)","key":"i2331-348X-30-1-17-b13","series-title":"Arch Pediatr Adolesc Med","first-page":"1140","article-title":"Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents","volume":"161","author":"Paul","year":"2007","unstructured":"Paul IM, Beiler J, McMonagle A, et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med. 2007;161(12):1140\u20131146."},{"issue":"(1 suppl)","key":"i2331-348X-30-1-17-b14","series-title":"Chest","first-page":"260S","article-title":"Guidelines for evaluating chronic cough in pediatrics: ACCP evidence-based clinical practice guidelines","volume":"129","author":"Chang","year":"2006","unstructured":"Chang AB, Glomb WB. Guidelines for evaluating chronic cough in pediatrics: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 suppl):260S\u2013283S."},{"key":"i2331-348X-30-1-17-b15","article-title":"What medications are kept behind the pharmacy counter? GoodRx","author":"Bonfin","year":"April 11, 2022","unstructured":"Bonfin S. What medications are kept behind the pharmacy counter? GoodRx. April 11, 2022. Accessed October 31, 2023. https:\/\/www.goodrx.com\/healthcare-access\/medication-education\/whats-behind-the-counter"},{"issue":"(6)","key":"i2331-348X-30-1-17-b16","series-title":"Pediatrics","first-page":"918","article-title":"Use of codeine- and dextromethorphan-containing cough remedies in children","volume":"99","year":"1997","unstructured":"Committee on Drugs. Use of codeine- and dextromethorphan-containing cough remedies in children. Pediatrics. 1997;99(6):918\u2013920."},{"issue":"(4)","key":"i2331-348X-30-1-17-b17","series-title":"Pediatrics","first-page":"e20162396","article-title":"Codeine: time to say \u201cNo\u201d","volume":"138","author":"Tobias","year":"2016","unstructured":"Tobias JD, Green TP, Cot\u00e9 CJ; Section on Anesthesiology and Pain Medicine; Committee on DruGS. Codeine: time to say \u201cNo\u201d. Pediatrics. 2016;138(4):e20162396."},{"key":"i2331-348X-30-1-17-b18","article-title":"Codeine Not to Be Used in Children Below 12 Years for Cough and Cold","year":"2015","unstructured":"European Medicines Agency. Codeine Not to Be Used in Children Below 12 Years for Cough and Cold. London, United Kingdom: European Medicines Agency; 2015. Accessed January 22, 2024. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/codeine-containing-medicinal-products-treatment-cough-or-cold-paediatric-patients"},{"key":"i2331-348X-30-1-17-b19","article-title":"FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older","year":"2018","unstructured":"US Food and Drug Administration. FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. 2018. Accessed October 31, 2023. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-requires-labeling-changes-prescription-opioid-cough-and-cold"},{"issue":"(1)","key":"i2331-348X-30-1-17-b20","series-title":"Chest","first-page":"303","article-title":"Managing chronic cough as a symptom in children and management algorithms: CHEST Guideline and Expert Panel Report","volume":"158","author":"Chang","year":"2020","unstructured":"Chang AB, Oppenheimer JJ, Irwin RS; CHEST Expert Cough Panel. Managing chronic cough as a symptom in children and management algorithms: CHEST Guideline and Expert Panel Report. Chest. 2020;158(1):303\u2013329."},{"issue":"(3)","key":"i2331-348X-30-1-17-b21","series-title":"J Pediatr Pharmacol Ther","first-page":"175","article-title":"Key potentially inappropriate drugs in pediatrics: the KIDs List","volume":"25","author":"Meyers","year":"2020","unstructured":"Meyers RS, Thackray J, Matson KL, et al. Key potentially inappropriate drugs in pediatrics: the KIDs List. J Pediatr Pharmacol Ther. 2020;25(3):175\u2013191."},{"issue":"(6)","key":"i2331-348X-30-1-17-b22","series-title":"Pediatrics","first-page":"e2022057779","article-title":"Benzonatate exposure trends and adverse events","volume":"150","author":"Kim","year":"2022","unstructured":"Kim I, Goulding M, Tian F, et al. Benzonatate exposure trends and adverse events. Pediatrics. 2022;150(6):e2022057779."},{"issue":"(4)","key":"i2331-348X-30-1-17-b23","series-title":"J Med Toxicol","first-page":"344","article-title":"Benzonatate overdose presenting as cardiac arrest with rapidly narrowing QRS interval","volume":"18","author":"Stephens","year":"2022","unstructured":"Stephens RJ, Filip AB, Baumgartner KT, et al. Benzonatate overdose presenting as cardiac arrest with rapidly narrowing QRS interval. J Med Toxicol. 2022;18(4):344\u2013349."},{"issue":"(7)","key":"i2331-348X-30-1-17-b24","series-title":"J Pediatr Pharmacol Ther","first-page":"642","article-title":"Arrhythmogenic antitussive: a case of pediatric benzonatate overdose with torsades de pointes, cardiac arrest, and complete recovery without neurologic deficits","volume":"25","author":"Billington","year":"2020","unstructured":"Billington M, Furmaga J, Schaeffer T. Arrhythmogenic antitussive: a case of pediatric benzonatate overdose with torsades de pointes, cardiac arrest, and complete recovery without neurologic deficits. J Pediatr Pharmacol Ther. 2020;25(7):642\u2013646."},{"issue":"(3)","key":"i2331-348X-30-1-17-b25","series-title":"J Pediatr Pharmacol Ther","first-page":"270","article-title":"Benzonatate toxicity in a teenager resulting in coma, seizures, and severe metabolic acidosis","volume":"17","author":"Thimann","year":"2012","unstructured":"Thimann DA, Huang CJ, Goto CS, Feng SY. Benzonatate toxicity in a teenager resulting in coma, seizures, and severe metabolic acidosis. J Pediatr Pharmacol Ther. 2012;17(3):270\u2013273."},{"issue":"(2)","key":"i2331-348X-30-1-17-b26","series-title":"J Emerg Med","first-page":"166","article-title":"Cardiac arrest with residual blindness after overdose of Tessalon\u00ae (benzonatate) perles","volume":"41","author":"Cohen","year":"2011","unstructured":"Cohen V, Jellinek SP, Stansfield L, et al. Cardiac arrest with residual blindness after overdose of Tessalon\u00ae (benzonatate) perles. J Emerg Med. 2011;41(2):166\u2013171."},{"key":"i2331-348X-30-1-17-b27","article-title":"FDA Drug Safety Communication: death resulting from overdose after accidental ingestion of Tessalon (benzonatate) by children under 10 years of age","year":"2017","unstructured":"US Food and Drug Administration. FDA Drug Safety Communication: death resulting from overdose after accidental ingestion of Tessalon (benzonatate) by children under 10 years of age. 2017. Accessed January 18, 2024. http:\/\/www.fda.gov\/drugs\/drugsafety\/ucm236651.htm"},{"key":"i2331-348X-30-1-17-b28","article-title":"Coughs and colds: medicines or home remedies?","year":"2022","unstructured":"American Academy of Pediatrics. Coughs and colds: medicines or home remedies? 2022. Accessed January 18, 2024. https:\/\/www.healthychildren.org\/English\/health-issues\/conditions\/chest-lungs\/Pages\/Coughs-and-Colds-Medicines-or-Home-Remedies.aspx"},{"issue":"(6)","key":"i2331-348X-30-1-17-b29","series-title":"Pediatr Rev","first-page":"316","article-title":"Acetaminophen poisoning","volume":"39","author":"Nadler","year":"2018","unstructured":"Nadler A, Fein DM. Acetaminophen poisoning. Pediatr Rev. 2018;39(6):316\u2013318."},{"issue":"(3)","key":"i2331-348X-30-1-17-b30","series-title":"Pediatr Rev","first-page":"107","article-title":"Management of ibuprofen overdose","volume":"18","author":"Zecca","year":"1997","unstructured":"Zecca TC. Management of ibuprofen overdose. Pediatr Rev. 1997;18(3):107."},{"issue":"(6)","key":"i2331-348X-30-1-17-b31","series-title":"PLoS One","first-page":"e0199493","article-title":"Safety of ibuprofen in infants younger than six months: a retrospective cohort study","volume":"13","author":"Walsh","year":"2018","unstructured":"Walsh P, Rothenberg SJ, Bang H. Safety of ibuprofen in infants younger than six months: a retrospective cohort study. PLoS One. 2018;13(6):e0199493."},{"issue":"(7)","key":"i2331-348X-30-1-17-b32","series-title":"Exp Dermatol","first-page":"993","article-title":"Pharmacogenomics for the efficacy and side effects of antihistamines","volume":"31","author":"Li","year":"2022","unstructured":"Li L, Liu R, Peng C, et al. Pharmacogenomics for the efficacy and side effects of antihistamines. Exp Dermatol. 2022;31(7):993\u20131004."},{"issue":"(1)","key":"i2331-348X-30-1-17-b33","series-title":"Arch Pediatr Adolesc Med","first-page":"105","article-title":"Diphenhydramine in infants","volume":"161","author":"Simons","year":"2007","unstructured":"Simons FE. Diphenhydramine in infants. Arch Pediatr Adolesc Med. 2007;161(1):105."},{"issue":"(11)","key":"i2331-348X-30-1-17-b34","series-title":"Cochrane Database Syst Rev","first-page":"CD001831","article-title":"Over-the-counter (OTC) medications for acute cough in children and adults in community settings","volume":"2014","author":"Smith","year":"2014","unstructured":"Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev. 2014;2014(11):CD001831."},{"issue":"(2)","key":"i2331-348X-30-1-17-b35","series-title":"J Med Assoc Thai","first-page":"96","article-title":"Effectiveness of antihistamines in common cold","volume":"73","author":"Sakchainanont","year":"1990","unstructured":"Sakchainanont B, Ruangkanchanasetr S, Chantarojanasiri T, et al. Effectiveness of antihistamines in common cold. J Med Assoc Thai. 1990;73(2):96\u2013101."},{"issue":"(3)","key":"i2331-348X-30-1-17-b36","series-title":"J Pediatr","first-page":"463","article-title":"Is an antihistamine-decongestant combination effective in temporarily relieving symptoms of the common cold in preschool children?","volume":"130","author":"Clemens","year":"1997","unstructured":"Clemens CJ, Taylor JA, Almquist JR, et al. Is an antihistamine-decongestant combination effective in temporarily relieving symptoms of the common cold in preschool children? J Pediatr. 1997;130(3):463\u2013466."},{"issue":"(1)","key":"i2331-348X-30-1-17-b37","series-title":"J Pediatr","first-page":"125","article-title":"Effectiveness of an antihistamine-decongestant combination for young children with the common cold: a randomized, controlled clinical trial","volume":"118","author":"Hutton","year":"1991","unstructured":"Hutton N, Wilson MH, Mellits ED, et al. Effectiveness of an antihistamine-decongestant combination for young children with the common cold: a randomized, controlled clinical trial. J Pediatr. 1991;118(1):125\u2013130."},{"issue":"(12)","key":"i2331-348X-30-1-17-b38","series-title":"J Clin Pharmacol","first-page":"1573","article-title":"A multicenter, randomized, placebo-controlled study of pseudoephedrine for the temporary relief of nasal congestion in children with the common cold","volume":"59","author":"Gelotte","year":"2019","unstructured":"Gelotte CK, Albrecht HH, Hynson J, Gallagher V. A multicenter, randomized, placebo-controlled study of pseudoephedrine for the temporary relief of nasal congestion in children with the common cold. J Clin Pharmacol. 2019;59(12):1573\u20131583."},{"key":"i2331-348X-30-1-17-b39","article-title":"Phenylpropanolamine (PPA) Information Page","year":"2016","unstructured":"US Food and Drug Administration. Phenylpropanolamine (PPA) Information Page. 2016. Accessed January 18, 2024. https:\/\/www.fda.gov\/drugs\/information-drug-class\/phenylpropanolamine-ppa-information-page"},{"key":"i2331-348X-30-1-17-b40","article-title":"Nonprescription Drug Advisory Committee Meeting. Efficacy of oral phenylephrine as a nasal decongestant","year":"2023","unstructured":"US Food and Drug Administration. Nonprescription Drug Advisory Committee Meeting. Efficacy of oral phenylephrine as a nasal decongestant. 2023. Accessed January 18, 2024. https:\/\/www.fda.gov\/media\/171915\/download"},{"issue":"(3)","key":"i2331-348X-30-1-17-b41","series-title":"Ann Pharmacother","first-page":"381","article-title":"Efficacy and safety of oral phenylephrine: systematic review and meta-analysis","volume":"41","author":"Hatton","year":"2007","unstructured":"Hatton RC, Winterstein AG, McKelvey RP, et al. Efficacy and safety of oral phenylephrine: systematic review and meta-analysis. Ann Pharmacother. 2007;41(3):381\u2013390."},{"key":"i2331-348X-30-1-17-b42","article-title":"Citizen\u2019s Petition 2015-P-4131-0001: Requesting a Final Rule Removing Oral Phenylephrine from the Final Monograph for OTC Nasal Decongestant Products","author":"Hendeles","unstructured":"Hendeles L, Hatton RC. Citizen\u2019s Petition 2015-P-4131-0001: Requesting a Final Rule Removing Oral Phenylephrine from the Final Monograph for OTC Nasal Decongestant Products. Accessed January 14, 2024. https:\/\/pink.citeline.com\/-\/media\/pmbi-old-site\/supporting-documents\/the-tan-sheet\/23\/45\/45-citizens-petitionphenylephrinenovember-2015.pdfURL"},{"issue":"(11)","key":"i2331-348X-30-1-17-b43","series-title":"Ann Pharmacother","first-page":"1275","article-title":"Why is oral phenylephrine on the market after compelling evidence of its ineffectiveness as a decongestant?","volume":"56","author":"Hatton","year":"2022","unstructured":"Hatton RC, Hendeles L. Why is oral phenylephrine on the market after compelling evidence of its ineffectiveness as a decongestant? Ann Pharmacother. 2022;56(11):1275\u20131278."},{"key":"i2331-348X-30-1-17-b44","article-title":"FDA clarifies results of recent advisory committee meeting on oral phenylephrine","year":"2023","unstructured":"US Food and Drug Administration. FDA clarifies results of recent advisory committee meeting on oral phenylephrine. 2023. Accessed January 18, 2024. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-clarifies-results-recent-advisory-committee-meeting-oral-phenylephrine"},{"key":"i2331-348X-30-1-17-b45","series-title":"New York Times","article-title":"Why the F.D.A. took so long to tackle a disputed cold remedy","author":"Jewett","year":"September 15, 2023","unstructured":"Jewett C. Why the F.D.A. took so long to tackle a disputed cold remedy. New York Times. September 15, 2023. Accessed February 25, 2024. https:\/\/www.nytimes.com\/2023\/09\/15\/health\/fda-cold-medicine-decongestant.html"},{"issue":"(6)","key":"i2331-348X-30-1-17-b46","series-title":"Ann Emerg Med","first-page":"655","article-title":"Pediatric poisoning from over-the-counter imidazoline-containing products","volume":"20","author":"Higgins","year":"1991","unstructured":"Higgins GL III, Campbell B, Wallace K, Talbot S. Pediatric poisoning from over-the-counter imidazoline-containing products. Ann Emerg Med. 1991;20(6):655\u2013658."},{"issue":"(5)","key":"i2331-348X-30-1-17-b47","series-title":"Respir Care","first-page":"631","article-title":"Guaifenesin has no effect on sputum volume or sputum properties in adolescents and adults with acute respiratory tract infections","volume":"59","author":"Hoffer-Schaefer","year":"2014","unstructured":"Hoffer-Schaefer A, Rozycki HJ, Yopp MA, Rubin BK. Guaifenesin has no effect on sputum volume or sputum properties in adolescents and adults with acute respiratory tract infections. Respir Care. 2014;59(5):631\u2013636."},{"key":"i2331-348X-30-1-17-b48","series-title":"Urol Case Rep","first-page":"102481","article-title":"Bilateral nephrolithiasis following ingestion of guaifenesin and dextromethorphan","volume":"50","author":"Kim","year":"2023","unstructured":"Kim E, Perlmutter M, Zweber H, Resch J. Bilateral nephrolithiasis following ingestion of guaifenesin and dextromethorphan. Urol Case Rep. 2023;50:102481."},{"issue":"(1)","key":"i2331-348X-30-1-17-b49","series-title":"J Emerg Med","first-page":"26","article-title":"Acute renal failure after ingestion of guaifenesin and dextromethorphan","volume":"47","author":"Small","year":"2014","unstructured":"Small E, Sandefur BJ. Acute renal failure after ingestion of guaifenesin and dextromethorphan. J Emerg Med. 2014;47(1):26\u201329."},{"key":"i2331-348X-30-1-17-b50","article-title":"Use caution when giving cough and cold products to kids","year":"2018","unstructured":"US Food and Drug Administration. Use caution when giving cough and cold products to kids. 2018. Accessed October 31, 2023. https:\/\/www.fda.gov\/drugs\/special-features\/use-caution-when-giving-cough-and-cold-products-kids"},{"issue":"(4)","key":"i2331-348X-30-1-17-b51","series-title":"Cochrane Database Syst Rev","first-page":"CD007094","article-title":"Honey for acute cough in children","volume":"4","author":"Oduwole","year":"2018","unstructured":"Oduwole O, Udoh EE, Oyo-Ita A, Meremikwu MM. Honey for acute cough in children. Cochrane Database Syst Rev. 2018;4(4):CD007094."},{"issue":"(6)","key":"i2331-348X-30-1-17-b52","series-title":"Pediatrics","first-page":"1092","article-title":"Vapor rub, petrolatum, and no treatment for children with nocturnal cough and cold symptoms","volume":"126","author":"Paul","year":"2010","unstructured":"Paul IM, Beiler JS, King TS, et al. Vapor rub, petrolatum, and no treatment for children with nocturnal cough and cold symptoms. Pediatrics. 2010;126(6):1092\u20131099."},{"issue":"(5)","key":"i2331-348X-30-1-17-b53","series-title":"Am J Ther","first-page":"324","article-title":"An open-label, single-center, phase IV clinical study of the effectiveness of zinc gluconate glycine lozenges (Cold-Eeze) in reducing the duration and symptoms of the common cold in school-aged subjects","volume":"10","author":"McElroy","year":"2003","unstructured":"McElroy BH, Miller SP. An open-label, single-center, phase IV clinical study of the effectiveness of zinc gluconate glycine lozenges (Cold-Eeze) in reducing the duration and symptoms of the common cold in school-aged subjects. Am J Ther. 2003;10(5):324\u2013329."},{"issue":"(3)","key":"i2331-348X-30-1-17-b54","series-title":"Paediatr Int Child Health","first-page":"145","article-title":"A randomized controlled trial of chelated zinc for prevention of the common cold in Thai school children","volume":"33","author":"Rerksuppaphol","year":"2013","unstructured":"Rerksuppaphol S, Rerksuppaphol L. A randomized controlled trial of chelated zinc for prevention of the common cold in Thai school children. Paediatr Int Child Health. 2013;33(3):145\u2013150."},{"issue":"(10)","key":"i2331-348X-30-1-17-b55","series-title":"Acta Paediatr","first-page":"1175","article-title":"The prophylactic and therapeutic effectiveness of zinc sulphate on common cold in children","volume":"95","author":"Kurug\u00f6l","year":"2006","unstructured":"Kurug\u00f6l Z, Akilli M, Bayram N, Koturoglu G. The prophylactic and therapeutic effectiveness of zinc sulphate on common cold in children. Acta Paediatr. 2006;95(10):1175\u20131181."},{"issue":"(6)","key":"i2331-348X-30-1-17-b56","series-title":"Pediatr Int","first-page":"842","article-title":"Effect of zinc sulfate on common cold in children: randomized, double blind study","volume":"49","author":"Kurug\u00f6l","year":"2007","unstructured":"Kurug\u00f6l Z, Bayram N, Atik T. Effect of zinc sulfate on common cold in children: randomized, double blind study. Pediatr Int. 2007;49(6):842\u2013847."},{"issue":"(1)","key":"i2331-348X-30-1-17-b57","series-title":"Cochrane Database Syst Rev","first-page":"CD000980","article-title":"Vitamin C for preventing and treating the common cold","volume":"2013","author":"Hemil\u00e4","year":"2013","unstructured":"Hemil\u00e4 H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;2013(1):CD000980."},{"issue":"(21)","key":"i2331-348X-30-1-17-b58","series-title":"JAMA","first-page":"2824","article-title":"Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial","volume":"290","author":"Taylor","year":"2003","unstructured":"Taylor JA, Weber W, Standish L, et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA. 2003;290(21):2824\u20132830."},{"issue":"(1)","key":"i2331-348X-30-1-17-b59","series-title":"Eur J Med Res","first-page":"33","article-title":"Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial","volume":"26","author":"Ogal","year":"2021","unstructured":"Ogal M, Johnston SL, Klein P, Schoop R. Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial. Eur J Med Res. 2021;26(1):33."},{"issue":"(3)","key":"i2331-348X-30-1-17-b60","series-title":"Arch Pediatr Adolesc Med","first-page":"217","article-title":"Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study","volume":"158","author":"Cohen","year":"2004","unstructured":"Cohen HA, Varsano I, Kahan E, et al. Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study. Arch Pediatr Adolesc Med. 2004;158(3):217\u2013221."},{"key":"i2331-348X-30-1-17-b61","article-title":"Guidance document: dosage delivery devices for orally ingested OTC liquid drug products","year":"2011","unstructured":"US Department of Health Human Services; US Food and Drug Administration. Guidance document: dosage delivery devices for orally ingested OTC liquid drug products. 2011. Accessed November 2, 2023. www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM188992.pdf"},{"issue":"(6)","key":"i2331-348X-30-1-17-b62","series-title":"Clin Pediatr (Phila)","first-page":"534","article-title":"Cold preparation use in young children after FDA warnings: do concerns still exist?","volume":"52","author":"Lazarus","year":"2013","unstructured":"Lazarus SG, Lanski SL, Smith AS, Simon HK. Cold preparation use in young children after FDA warnings: do concerns still exist? Clin Pediatr (Phila). 2013;52(6):534\u2013539."},{"issue":"(1)","key":"i2331-348X-30-1-17-b63","series-title":"Pediatr Emerg Care","first-page":"e100","article-title":"Adverse events related to accidental unintentional ingestions from cough and cold medications in children","volume":"38","author":"Wang","year":"2022","unstructured":"Wang GS, Reynolds KM, Banner W, et al. Adverse events related to accidental unintentional ingestions from cough and cold medications in children. Pediatr Emerg Care. 2022;38(1):e100\u2013e104."},{"issue":"(5)","key":"i2331-348X-30-1-17-b64","series-title":"Pediatrics","first-page":"e2020049536","article-title":"Pediatric fatalities associated with over-the-counter cough and cold medications","volume":"148","author":"Halmo","year":"2021","unstructured":"Halmo LS, Wang GS, Reynolds KM, et al. Pediatric fatalities associated with over-the-counter cough and cold medications. Pediatrics. 2021;148(5):e2020049536."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/30\/1\/article-p17.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/30\/1\/article-p17.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/30\/1\/article-p17.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T14:25:34Z","timestamp":1745245534000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/30\/1\/article-p17.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":64,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-30.1.17","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"value":"2331-348X","type":"electronic"},{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}